No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
OCGN240517P2500
- 0.76
- +0.02+2.70%
15min DelayClose May 14 15:59 ET
0.90High0.75Low
0.90Open0.74Pre Close43 Volume26 Open Interest2.50Strike Price3.28KTurnover315.87%IV-1.47%PremiumMay 17, 2024Expiry Date0.80Intrinsic Value100Multiplier3DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type-0.8802Delta0.4044Gamma2.06Leverage Ratio-0.0143Theta-0.0002Rho-1.81Eff Leverage0.0003Vega
Intraday
- 5D
- 1D
News
Ocugen Q1 2024 GAAP EPS $(0.05) Beats $(0.06) Estimate, Sales $1.014M Up From $443.000K YoY
Ocugen Q1 2024 GAAP EPS $(0.05) Beats $(0.06) Estimate, Sales $1.014M Up From $443.000K YoY
Earnings Call Summary | Ocugen(OCGN.US) Q1 2024 Earnings Conference
The following is a summary of the Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript:Financial Performance:Ocugen's R&D expenses for Q1 2024 were $6.8 million, a decrease compared to $10.2 million i
Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript
Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript
Express News | Ocugen Inc Qtrly Shr Loss $0.05
Express News | Ocugen Inc: Ocu400 on Track to Meet 2026 Biologics License Application (Bla) and Market Authorization Application (Maa) Approval Targets
Express News | Ocugen Q1 Net Income USD -11.924 Million
Comments
$Ocugen(OCGN.US$ this stock is good to hold long, love it 🩵
2
1
$Ocugen(OCGN.US$ Ocugen Q1 2024 GAAP EPS $(0.05) Beats $(0.06) Estimate, Sales $1.014M Up From $443.000K YoY
5
$Ocugen(OCGN.US$ stay tune, 8.30am ET quarter earning release 🚀🚀
2
$Ocugen(OCGN.US$ Well this keep going tomorrow?
4
Read more
Trytosaveabit : Yes it’s a longer hold! Nice pipeline but kinda far out there! But I like it as well! GL